SCHEMBL25331335

SCHEMBL25331335

CS(=O)(=O)c1cccc(Nc2ncc(Cl)c(-c3c[nH]c4c([N+](=O)[O-])cccc34)n2)c1F

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ JAK1 P23458 18/20 0.62
▸ JAK2 O60674 15/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21751129 0.92 JAK1 (0.61) JAK1JAK2
SCHEMBL30018516 0.92 JAK1 (0.61) JAK1JAK2
SCHEMBL20400706 0.91 JAK2 (0.62) JAK1JAK2
SCHEMBL30018202 0.91 JAK2 (0.62) JAK1JAK2
SCHEMBL23522368 0.86 JAK1 (0.65) JAK1JAK2
SCHEMBL20400701 0.83 JAK2 (0.63) JAK1JAK2
SCHEMBL30018494 0.83 JAK2 (0.63) JAK1JAK2
SCHEMBL23130598 0.83 JAK2 (0.53) JAK1JAK2
SCHEMBL23130600 0.81 JAK2 (0.65) JAK1JAK2
SCHEMBL30092437 0.81 JAK2 (0.65) JAK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219470-A1 JAK1 SELECTIVE INHIBITORS Astrazeneca AB (SE) 2023-08-02 — — EP disclosed
EP-3571192-B1 JAK1 SELECTIVE INHIBITORS ASTRAZENECA AB (SE) 2022-11-30 — — EP disclosed
Send feedback